Entheogen focuses on psychedelics used in therapeutic, medicinal, sacramental, and recreational contexts.
http://entheogenshow.com/
Gesamtlänge aller Episoden: 1 day 7 hours 58 minutes
045 Stealing Fire, Part 1
Part One - The Case for Ecstasis. “The alternative is unconsciousness, the default setting, the rat race, the constant gnawing sense of having had, and lost, some infinite thing.” —David Foster Wallace
episode 1: 044: Interview with Dr. Rosalind Watts, Clinical Psychologist in the Psychedelic Research Group at Imperial College London
This is Entheogen. Elevate the Conversation. Please support Entheogen by making a donation on Patreon. Become a Patron for as little as $1. Pledge just $3 or more, and get early access to new episodes, plus exclusive Patron-only features. Head over to EntheogenShow.com and click on Support.
043: The LSD-assisted Dock Ellis No-Hitter
This is Entheogen. Elevate the Conversation. It’s March 5, 2017, and we are discussing the famous LSD-assisted Dock Ellis No-Hitter.
042: Interview with Dr. Neal Goldsmith on Psychedelic Healing
This is Entheogen. Elevate the Conversation. It’s March 12, 2017, and we are discussing psychedelic healing with Dr. Neal Goldsmith.
041: Reflections on our Burning Man 2016 Interview with Alex Grey, Allyson Grey, Rick Doblin
It’s February 26, 2017, and we are reflecting on our conversation with Alex Grey, Allyson Grey, and Rick Doblin at Burning Man 2016.
040: Checking in with Kirk Rutter, Psilocybin Research Participant
It’s February 26, 2017, and we are checking in with Kirk Rutter, who joined us for Episode 025: Psychedelic Medicine Trials with Participant Kirk Rutter.
039: Reflections on Our Interview with Dr. Julie Holland
Today is July 20, 2016, and we are reflecting on our interview with Dr. Julie Holland from last season. Your pledges make the show possible! We're trying to cover expenses by asking our fans to pledge at Patreon.com/Entheogen. We really appreciate your support!
038: Interview with Alasdair from Bluelight.org
Today is December 4, 2016, and we are talking with Alisdair from BlueLight.org.
037: Dr. Sarah Mennenga from NYU Experimental Therapeutics Laboratory on Using Psilocybin to Treat Anxiety and Depression in Cancer Patients
Today is December 18, 2016, and we are discussing the recent publication of studies from NYU and Johns Hopkins showing that psilocybin can reduce anxiety and depression in cancer patients, and we’re pleased to be joined by Dr. Sarah Mennenga from the NYU Experimental Therapeutics Laboratory.